Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
TalkMed Group Ltd. ( (SG:5G3) ) has provided an update.
TalkMed Group Ltd. addressed a shareholder’s query regarding the proposed acquisition of all its issued and paid-up shares by TW Troy Ltd. at $0.456 per share. The company is currently navigating through regulatory and procedural requirements necessary for the transaction, including obtaining approvals from regulators and shareholders. The Board assured shareholders that updates, including the independent financial adviser’s advice and independent directors’ recommendations, will be shared in due course, thanking them for their patience.
More about TalkMed Group Ltd.
TalkMed Group Ltd. operates in the healthcare industry, focusing on providing specialized medical oncology services. The company is based in Singapore and works collaboratively with its subsidiaries to deliver comprehensive cancer care solutions.
YTD Price Performance: 2.27%
Average Trading Volume: 83,012
Technical Sentiment Signal: Sell
Current Market Cap: S$598.6M
Learn more about 5G3 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue